Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ SPARC AI Inc. Announces Closing of First Tranche of Brokered LIFE Financing for $4.34 Million from an... (GlobeNewswire EN) +++ SPARC AI Aktie +3,82%

News zum Sektor Gesundheit aus Kanada

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1550 Aktien zum Sektor Gesundheit bekannt.
 
03.06.26 - 23:15
Helix BioPharma Corp. Announces Closing of Private Placement of Convertible Debentures (The Newswire)
 
  Vancouver, British Columbia – TheNewswire - 3 June, 2026 – Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCF”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, announces that it has closed a non-brokered private placement (the “Offering”) of unsecured convertible debentures of the Company (each, a “Convertible Debenture”). The Company issued 3,673 Convertible Debentures for aggregate gross proceeds of C$3,673,000 pursuant to the Offering. The principal amount and any unpaid accrued interest of the Convertible Debentures will be due and payable 14 months from the closing date of the private placement (the “Maturity Date”). Each Convertible Debenture will bear interest at 25.00% per annum, calculated on a simple interest basis. If the Convertible Debentures are not repaid on or prior to the Maturity Date, the outstanding principal amount of the Convertible Deben...
03.06.26 - 22:09
Red White & Bloom Brands′ Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group (GlobeNewswire EN)
 
RWB's Emblem assumes Ayurcann's $1.6M DIP facility and commits up to $3M to support CCAA operations ahead of the planned Ayurcann acquisition...
03.06.26 - 21:18
ME Therapeutics Announces Private Placement (Business Wire)
 
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICESVANCOUVER, British Columbia--(BUSINESS WIRE)--ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company working on novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer, is pleased to announce a non-brokered private placement to raise gross proceeds of up to $500,000 (the “Offering”) through the issuance of up to 294,117 units (each a “Unit”) at $1.70 per Unit. Each Unit will be comprised of one common share (a “Share') and one non-transferrable common share purchase warrant (a “Warrant”), with each Warrant being exercisable into one additional Share at an exercise price of $2.00 each for three years from the date of issuance, subject to an acceleration clause whereby, if the volume weighted average price of the Shares is at or above $3.00 for ten consecutive trading days, the Company may accelerat...
03.06.26 - 16:03
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026 (GlobeNewswire EN)
 
DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. ...
03.06.26 - 13:48
Curaleaf Confirms Effective Date of Reverse Stock Split (PR Newswire)
 
STAMFORD, Conn., June 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today confirms that the previously announced 1-for-3 reverse stock split of its subordinate......
03.06.26 - 13:12
Theralase Technologies Inc.: Theralase(R) Lists Warrants on the TSXV (Newsfile)
 
Toronto, Ontario--(Newsfile Corp. - June 3, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to the ......
03.06.26 - 12:42
Restart Life Sciences names Inez Ho CFO; Rebecca Hudson resigns (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.06.26 - 12:06
High Tide kündigt die Veröffentlichung der Finanzergebnisse für das zweite Geschäftsquartal 2026 an (IRW Press)
 
CALGARY, AB /3. Juni 2026 / IRW-Press / High Tide Inc. (High Tide oder das Unternehmen) (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA) ein erfolgreiches und auf den Einzelhandel ausgerichtetes Unternehmen,......
03.06.26 - 12:06
Restart Life Sciences Corp.: Restart Life Sciences Appoints Inez Ho as Chief Financial Officer (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the ap......
03.06.26 - 12:06
Thiogenesis Therapeutics, Corp.: Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million (Newsfile)
 
San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-gener......
03.06.26 - 12:03
High Tide to Announce Second Fiscal Quarter 2026 Financial Results (PR Newswire)
 
CALGARY, AB, June 3, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it will release its......
03.06.26 - 10:00
Tang Capital takes 10% stake in Aurinia Pharma (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.06.26 - 09:30
Defence Therapeutics Inc.: Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors (Newsfile)
 
Montreal, Quebec--(Newsfile Corp. - June 3, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intra......
03.06.26 - 09:24
Defence Therapeutics begrüßt den erfahrenen Biopharma-Führungsexperten Dr. John Beaver in seinem Board of Directors (IRW Press)
 
Montreal, QC, Kanada, 3. Juni 2026 / IRW-Press / Defence Therapeutics Inc. (Defence oder das Unternehmen) (CSE: DTC, OTCQB: DTCFF, FWB: DTC) ein börsennotiertes Biotechnologieunternehmen, das sich......
03.06.26 - 09:06
Herbal Dispatch Inc.: Herbal Dispatch Inc. Appoints Jason Spatafora as Strategic Advisor (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and di......
03.06.26 - 02:27
Hydreight Announces Refiling of Interim Financial Statements (PR Newswire)
 
VANCOUVER, BC and LAS VEGAS, June 2, 2026 /PRNewswire/ - Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, announces that it has refiled its condensed interim consolidated financial......
03.06.26 - 01:45
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts (Zacks)
 
The latest trading day saw Canopy Growth Corporation (CGC) settling at $1.06, representing a -1.85% change from its previous close....
03.06.26 - 00:06
Onco-Innovations treibt Skalierung des B4-Vorläufers auf 1 kg zur Unterstützung der Herstellung von ONC010 und des klinischen Entwicklungsprogramms voran (IRW Press)
 
Kündigt außerdem ein Marketingprogramm an Vancouver, Kanada 2. Juni 2026 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (FWB: W1H, WKN: A3EKSZ) (Onco oder das Unternehmen)......
03.06.26 - 00:03
Onco-Innovations Limited: Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program (Accesswire)
 
Also Announces Marketing Program VANCOUVER, BC / ACCESS Newswire / June 2, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") announc......
02.06.26 - 22:09
BriaCell Therapeutics Announces Closing of Offering (GlobeNewswire EN)
 
PHILADELPHIA & VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the closing of its best-efforts offering of 1,449,300 common shares. Each common share was sold at an offering price of $3.25 per share. All of the common shares in the offering were offered by the Company. Total gross proceeds from the offering, before deducting placement agent's fees and other offering expenses, were approximately $4.7 million. The Company relied upon the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible interlisted issuers on a recognized exchange, such as Nasdaq....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn in Salzburg nicht endlich ein wirklich geistiger Prozess eingeleitet wird, ist das Festival am Ende. - Dr. Gérard Mortier
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!